MannKind Corporation (NASDAQ:MNKD) shares are tumbling 6.87% in mid-day trading to $5.
Jefferies analyst Shaunak Deepak weighed in with his opinions on MannKind Corporation (NASDAQ:MNKD), following positive feedback from physicians from the American Diabetes Association on the Diabetes …
MannKind Corporation (NASDAQ:MNKD) shares increased more than 2% in pre-market trading to $6.25 after Shaunak Deepak, an analyst at Jefferies, reiterated a Buy …
MannKind Corporation (NASDAQ:MNKD), focused on discovering, developing and commercializing treatments for diabetes, announced that it will present at upcoming conferences. Jefferies 2015 Global …
MannKind Corporation (NASDAQ:MNKD) has had a bit of a hard time over the past few months. However, about 2 weeks ago, that all …
MannKind Corporation (NASDAQ:MNKD) announced that James S. Shannon, MD, MRCP (UK) has been elected to the company’s Board of Directors after previously serving …
MannKind Corporation (NASDAQ:MNKD) Throughout the past few months, MannKind has had a relatively rough time in the market. Starting with a downgrade …
MannKind Corporation (NASDAQ:MNKD) MannKind stock has had a great beginning to the week so far. After a strong Friday, the gains continued …
MannKind Corporation (NASDAQ:MNKD) shares increased approximately 4.5% in pre-market trading to $4.
MannKind Corporation (NASDAQ:MNKD) Following the recent declines that we’ve seen from the stock, MannKind is having a great day in the market …
